Tag: biotech

Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results

TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the three and nine months ended June 30, 2025 and provided an update on its business.

Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights

SAN DIEGO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease, today reported its second quarter 2025 operating and financial results and reviewed recent business highlights.

WCC Biomedical@NACDS Total Store Expo: Advancing Microneedle Drug Delivery With WINMAP™ Platform

TAIPEI, Aug. 8, 2025 /PRNewswire/ -- WCC Biomedical, a leader in novel drug delivery systems, will attend the upcoming NACDS Total Store Expo (TSE), where...

RBL LLC secures investment from Modi Ventures

- Strategic investment to support RBL's mission to launch and scale breakthrough startups - Founder and general partner of Modi Ventures, Sahir Ali, to join...

ALMORA BOTANICA GRANTED TWO GROUNDBREAKING PATENTS

A New Era of Ayurvedic Skincare Innovation LONDON, Aug. 7, 2025 /PRNewswire/ -- Almora Botanica, the pioneering science-first Ayurvedic skincare brand, has secured two groundbreaking...

Women In Bio Announces New Boardroom Ready Cohort

DALLAS, Aug. 7, 2025 /PRNewswire/ -- Women In Bio (WIB), in collaboration with sponsor, Latham & Watkins, celebrates the newest cohort for the Boardroom Ready...

XtalPi and DoveTree Announce Landmark $6 Billion AI Drug Discovery Collaboration

Strategic partnership leverages AI and robotics for novel therapeutics across oncology, immunology, inflammation, neurology, and metabolic diseases. CAMBRIDGE, Mass., Aug. 7, 2025 /PRNewswire/ -- XtalPi...

XtalPi and DoveTree Announce Landmark $6 Billion AI Drug Discovery Collaboration

Strategic partnership leverages AI and robotics for novel therapeutics across oncology, immunology, inflammation, neurology, and metabolic diseases. CAMBRIDGE, Mass., Aug. 6, 2025 /PRNewswire/ -- XtalPi...

CLK Inhibitors Market Poised for Growth as Demand Rises in Oncology and Musculoskeletal Disorders | DelveInsight

The CLK inhibitors market is projected to expand in the coming years, driven by a rising incidence of cancer diagnoses, growing awareness of these...

CLK Inhibitors Market Poised for Growth as Demand Rises in Oncology and Musculoskeletal Disorders | DelveInsight

The CLK inhibitors market is projected to expand in the coming years, driven by a rising incidence of cancer diagnoses, growing awareness of these...

FIRSTLINE AND THE JACKSONVILLE JAGUARS ANNOUNCE PARTNERSHIP TO PROMOTE WORKFORCE VISION HEALTH

The two-year agreement is a groundbreaking partnership between the National Football League franchise and a Black-owned, Jacksonville-based vision health tech startup JACKSONVILLE, Fla., Aug. 6,...

HYLENR Closes Pre-Series A Funding to Commercialise Low-Energy Nuclear Reaction Systems

The Pre-Series A Funding Marks Transition from Breakthrough Research to Prototyping, Validates LENR as a Scalable Clean Energy Alternative HYDERABAD, India, Aug. 6, 2025 /PRNewswire/...

HYLENR Closes Pre-Series A Funding to Commercialise Low-Energy Nuclear Reaction Systems

The Pre-Series A Funding Marks Transition from Breakthrough Research to Prototyping, Validates LENR as a Scalable Clean Energy Alternative HYDERABAD, India, Aug. 6, 2025 /PRNewswire/...

Nxera Launches Broad Proprietary Pipeline Targeting Obesity and Chronic Weight Management

Tokyo, Japan and Cambridge, UK, 6 August 2025 – Nxera Pharma Co., Ltd. (“Nxera”; TSE: 4565) a technology-powered biopharmaceutical company, today announces the launch of a broad new pipeline strategically focused on advancing next-generation therapies for obesity and associated metabolic disorders.

ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WGS

Canada Council for the Arts invests $25 million to strengthen Alberta arts communities

Modat adds Passive DNS to its Platform Magnify, Connecting Every Signal in a Single Investigation Graph

Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results

Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights

WCC Biomedical@NACDS Total Store Expo: Advancing Microneedle Drug Delivery With WINMAP™ Platform

RBL LLC secures investment from Modi Ventures

ALMORA BOTANICA GRANTED TWO GROUNDBREAKING PATENTS

Women In Bio Announces New Boardroom Ready Cohort

XtalPi and DoveTree Announce Landmark $6 Billion AI Drug Discovery Collaboration

XtalPi and DoveTree Announce Landmark $6 Billion AI Drug Discovery Collaboration

CLK Inhibitors Market Poised for Growth as Demand Rises in Oncology and Musculoskeletal Disorders | DelveInsight

CLK Inhibitors Market Poised for Growth as Demand Rises in Oncology and Musculoskeletal Disorders | DelveInsight

FIRSTLINE AND THE JACKSONVILLE JAGUARS ANNOUNCE PARTNERSHIP TO PROMOTE WORKFORCE VISION HEALTH

HYLENR Closes Pre-Series A Funding to Commercialise Low-Energy Nuclear Reaction Systems

HYLENR Closes Pre-Series A Funding to Commercialise Low-Energy Nuclear Reaction Systems

Nxera Launches Broad Proprietary Pipeline Targeting Obesity and Chronic Weight Management

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us